Location History:
- Columbia, MD (US) (2005)
- Baltimore, MD (US) (2022)
- Pikesville, MD (US) (2014 - 2024)
Company Filing History:
8 out of 3,687 
1 out of 4,770 
Years Active: 2005-2024
Title: Livia Angela Casciola-Rosen: Innovator in Cancer Research
Introduction
Livia Angela Casciola-Rosen is a prominent inventor based in Pikesville, MD (US). She has made significant contributions to the field of cancer research, particularly in the development of innovative therapeutic and diagnostic methods. With a total of 8 patents, her work focuses on the intersection of autoimmune diseases and cancer.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Autoimmune antibodies for use in inhibiting cancer cell growth." This patent provides compositions, such as autoantibodies, that inhibit the growth, viability, or mobility of cancer cells. Additionally, it outlines applications for therapeutic and diagnostic methods, as well as screening methods for identifying useful autoantibodies. Another notable patent is related to "Materials and methods for assessing cancer risk and treating cancer." This document discusses materials and methods for assessing and treating subjects with autoimmune diseases, providing insights into identifying individuals at higher or lower risk of cancer.
Career Highlights
Livia has worked with esteemed organizations such as The Johns Hopkins University and Merck & Company, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Some of her notable coworkers include Antony Rosen and Lisa Christopher-Stine. Their collaborative efforts have further enhanced the impact of her research and innovations.
Conclusion
Livia Angela Casciola-Rosen is a trailblazer in the realm of cancer research, with a focus on autoimmune diseases. Her innovative patents and collaborations have the potential to transform therapeutic approaches and improve patient outcomes.